Original Investigation

Bacterial Decolonization With Mupirocin Ointment for Acute Radiation Oral Mucositis Prevention

JAMA Oncology 10.1001/jamaoncol.2025.2361

August 07, 2025 at 11:00 AM EDT

Read the full article

Is bacterial decolonization (BD) with mupirocin able to alleviate severe acute radiation oral mucositis (AROM, grade ≥3) in patients undergoing radiotherapy for nasopharyngeal carcinoma?This open-label phase 3 randomized clinical trial of 176 patients showed that BD therapy reduced severe AROM rate by more than half (from 48% to 23%) during radiotherapy. It also alleviated oral pain and swallowing difficulties and reduced oral colonization rates.These results indicate that BD is a promising and cost-effective strategy for alleviating AROM in patients with nasopharyngeal carcinoma undergoing radiotherapy.

Corresponding Authors: Tianzhu Lu, MD, PhD (ndzhlyy1941@ncu.edu.cn) and Jingao Li, MD (lijingao@hotmail.com), Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, 519 Beijing E Rd, Nanchang, Jiangxi 330029, China.

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2025.2361?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080725

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks